Table 3.
Endpoint events in MHD patients with different risk factors
| Characteristic | Without PH or HVC (n = 138) | With PH or HVC (n = 121) | With PH and HVC (n = 43) |
|---|---|---|---|
| All-cause death | 18 (13.0) | 29 (24.0) | 16 (37.2)a |
| Cardiovascular death | 7 (5.1) | 16 (13.2) | 13 (30.2)a |
| New cardiovascular events | 28 (20.3) | 43 (35.5)b | 29 (67.4)a |
| Cardiac event | 20 (14.5) | 36 (29.8)c | 26 (60.5)a,d |
| Angina pectoris | 5 (3.6) | 4 (3.3) | 6 (14.0) |
| Acute myocardial infarction | 2 (1.4) | 6 (5.0) | 6 (14)c |
| Acute heart failure | 7 (5.1) | 20 (16.5)c | 6 (14) |
| Severe arrhythmia | 4 (2.9) | 10 (8.3) | 8 (18.6)c |
| Sudden death | 4 (2.9) | 7 (5.8) | 7 (16.3)b |
| Cerebrovascular event | 9 (6.5) | 11 (9.1) | 8 (18.6) |
| Stroke | 7 (5.1) | 9 (7.4) | 7 (16.3) |
| Transient ischemic attack | 2 (1.4) | 2 (1.7) | 1 (2.3) |
| Peripheral vascular disease | 1 (0.7) | 2 (1.7) | 0 |
a p < 0.001 compared to 0-risk factor group.
b p < 0.05 compared to 0-risk factor group.
c p < 0.01 compared to 0-risk factor group.
d p < 0.001 compared to 1-risk factor group.